 LA JOLLA, Calif., May 26, 2021 GLOBE NEWSWIRE -- Singular Genomics Systems, Inc. Singular Genomics, a company focused on delivering genomic technologies for the advancement of science and medicine, today announced the pricing of its upsized initial public offering of 10,200,000 shares of its common stock at an initial public offering price of 22.00 per share. All of the shares of common stock are being offered by Singular Genomics. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Singular Genomics, are expected to be 224.4 million. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol OMIC on May 27, 2021. The offering is expected to close on June 1, 2021, subject to the satisfaction of customary closing conditions. In addition, Singular Genomics has granted the underwriters a 30-day option to purchase an additional 1,530,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. 